These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32015033)

  • 1. Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against
    Moon SH; Kaufmann Y; Huang E
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopeptide Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against Carbapenem-Resistant Pathogens.
    Moon SH; Huang E
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in
    Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Antimicrobial Activity of Colistin in Combination with Rifampin and Azithromycin against Escherichia coli Producing MCR-1.
    Li Y; Lin X; Yao X; Huang Y; Liu W; Ma T; Fang B
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin Combinations Combat
    Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infection.
    Moon SH; Kaufmann Y; Fujiwara R; Huang E
    BMC Microbiol; 2021 Nov; 21(1):326. PubMed ID: 34819026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin overcomes MCR-mediated colistin resistance in Gram-negative pathogens.
    Liu Y; Jia Y; Yang K; Tong Z; Shi J; Li R; Xiao X; Ren W; Hardeland R; Reiter RJ; Wang Z
    Theranostics; 2020; 10(23):10697-10711. PubMed ID: 32929375
    [No Abstract]   [Full Text] [Related]  

  • 8. Low level of polymyxin resistance among nonclonal mcr-1-positive Escherichia coli from human sources in Brazil.
    Pillonetto M; Mazzetti A; Becker GN; Siebra CA; Arend LNVS; Barth AL
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):140-142. PubMed ID: 30355469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.
    Tyrrell JM; Aboklaish AF; Walsh TR; Vaara T; Vaara M
    Peptides; 2019 Feb; 112():149-153. PubMed ID: 30586602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
    Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
    J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-resistance to human cationic antimicrobial peptides and to polymyxins mediated by the plasmid-encoded MCR-1?
    Dobias J; Poirel L; Nordmann P
    Clin Microbiol Infect; 2017 Sep; 23(9):676.e1-676.e5. PubMed ID: 28344161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics.
    MacNair CR; Stokes JM; Carfrae LA; Fiebig-Comyn AA; Coombes BK; Mulvey MR; Brown ED
    Nat Commun; 2018 Jan; 9(1):458. PubMed ID: 29386620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxin causes cell envelope remodelling and stress responses in mcr-1-harbouring Escherichia coli.
    Nang SC; Li M; Harper M; Mandela E; Bergen PJ; Rolain JM; Zhu Y; Velkov T; Li J
    Int J Antimicrob Agents; 2022 Feb; 59(2):106505. PubMed ID: 34954369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Linear Lipopeptide Paenipeptins with Potential for Eradicating Biofilms and Sensitizing Gram-Negative Bacteria to Rifampicin and Clarithromycin.
    Moon SH; Zhang X; Zheng G; Meeker DG; Smeltzer MS; Huang E
    J Med Chem; 2017 Dec; 60(23):9630-9640. PubMed ID: 29136469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel plasmid-mediated polymyxin resistance determinant (mcr-1.8) in Escherichia coli recovered from broiler chickens in Brunei Darussalam.
    Abdul Momin MHF; Liakopoulos A; Bean DC; Phee LM; Wareham DW
    J Antimicrob Chemother; 2019 Nov; 74(11):3392-3394. PubMed ID: 31504534
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of the ATP synthase increases sensitivity of Escherichia coli carrying mcr-1 to polymyxin B.
    Fan Z; Li Z; Fu T; Feng Y; Chen Y; Liu H; Du B; Cui X; Zhao H; Xue G; Cui J; Yan C; Gan L; Feng J; Xu Z; Yu Z; Yuan J
    J Antibiot (Tokyo); 2024 Oct; 77(10):685-696. PubMed ID: 38914795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test.
    Dortet L; Bonnin RA; Pennisi I; Gauthier L; Jousset AB; Dabos L; Furniss RCD; Mavridou DAI; Bogaerts P; Glupczynski Y; Potron A; Plesiat P; Beyrouthy R; Robin F; Bonnet R; Naas T; Filloux A; Larrouy-Maumus G
    J Antimicrob Chemother; 2018 Dec; 73(12):3359-3367. PubMed ID: 30184212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of EDTA and Dipicolinic Acid in Broth Microdilution with Polymyxin B as a Phenotypic Test to Detect the
    Wink PL; Caierão J; Nunes AGA; Collar GDS; Martins JB; Dalmolin TV; Pilonetto M; Barth AL
    Microb Drug Resist; 2020 Apr; 26(4):329-333. PubMed ID: 31592718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colistin resistance gene mcr-1 in gut flora of children.
    Hu YY; Wang YL; Sun QL; Huang ZX; Wang HY; Zhang R; Chen GX
    Int J Antimicrob Agents; 2017 Oct; 50(4):593-597. PubMed ID: 28668691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli.
    Smith NM; Bulman ZP; Sieron AO; Bulitta JB; Holden PN; Nation RL; Li J; Wright GD; Tsuji BT
    J Antimicrob Chemother; 2017 Aug; 72(8):2297-2303. PubMed ID: 28505268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.